L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.
Privately held pharmaceutical company dedicated to R&D of novel compounds for the treatment of cancers and viral diseases. Validated assays to test drugs, disinfectants and devices against COVID-19 offered by a highly qualified team.
Sassari, Sardinia, Italy
Send a message
Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) as well as other respiratory viruses are mainly transmitted through aerosols , where they can be stable and viable for several hours.
Our Aerosol testing technology can provide rapid and deep insight for your research against SARS-CoV-2 and all other respiratory viruses.
Discover whether your molecule, device or disinfectant have virucidal activity against viruses. With a dedicated BSL3 laboratory, our Scientists will carry out efficacy testing services and studies on molecules, disinfectant products, materials with antiviral properties, and devices for disinfection or sanitization of air or surfaces.
Please contact us to learn more or request a quote -> email@example.com
ViroStatics and biotx.ai partner up to develop CDK6 inhibitors for the treatment of acute respiratory distress syndrome (ARDS) and COVID-19.
This will close major therapeutic gaps in the treatment of COVID-19 and better prepare the world for future SARS pandemics.
In detail, in order to develop more specialized CDK6 treatments, the two Companies will develop and investigate ViroStatics’ CDK6 inhibitor VS2-370.
Early results are promising and we are optimistic that we will make major contributions to the development of drugs against all COVID-19 variants, future SARS pandemics, and ARDS.
Looking for expertise in Laboratory Testing? ViroStatics can be your strategic Partner.
Our Team of qualified experts deliver proactive services and professional advise to support your research, ensuring our methods and testing services meet the highest level of scrutiny under complex quality control and regulatory requirements, in compliance with the guidelines for handling viruses in high biological containment laboratories (BSL3).
If you want to learn more, please contact Davide De Forni, PhD at firstname.lastname@example.org.
ViroStatics has the expertise to now determine antiviral activity on textile products and other porous materials according to ISO 18184:2019 guidelines.
Our Experts at ViroStatics continue to bring forth a variety of testing solutions against SARS-CoV-2 and other viruses (HIV and Flu) creating innovative, multi-target assay design to deal with current and future emerging SARS-CoV-2 mutations and faster workflow options. Contact us to learn more: email@example.com
Global Business Reports (GBR) published the first Digital Version of Italy Life Sciences Report - 2021. It is a detailed Report of insights from leading-executive voices across the value chain, from the country’s foundational APIs and CDMO industry, to cutting-edge innovators in oncology, rarediseases, ophthalmology, and many others.
You can find within the Digital Italy Life Sciences 2021 Publication, mentions of ViroStatics and quotations within the editorial at Page 36, 43 and 47.
Enjoy the reading.